|
CerubidineDrug - Cerubidine The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Daunorubicin Hydrochloride
Strength -
EQ 20MG BASE/VIAL
Applicant -
AVENTIS
New Drug Application (NDA) Number -
061876
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Aventis Pharmaceutical Products Inc
Cerubidine
Rev-eyes 0.5% Solution/drops; Ophthalmic
Aczone 5% Gel; Topical Dapsone 100mg Tablet; Oral Dapsone 25mg Tablet; Oral Cubicin 250mg/vial Injectable; Iv (infusion) Cubicin 500mg/vial Injectable; Iv (infusion) Enablex Eq 15mg Base Tablet, Extended Release; Oral Enablex Eq 7.5mg Base Tablet, Extended Release; Oral Daunoxome Eq 2mg Base/ml Injectable, Liposomal; Injection Cerubidine Eq 20mg Base/vial Injectable; Injection NewDrugInformation |